Stock listing
NASDAQ:CNTX Context Therapeutics Inc. Stock
Home listing (NASDAQ) of Context Therapeutics Inc.
Follow Context Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CNTX
$0.189 USD -0.013 (-6.2%)
Close on Oct 30, 2026
- Day range
- $0.189 – $0.203 USDOct 30, 2026
- Volume
- 1.01M sharesOct 30, 2026
- Market cap
- $17.37M USDAt the close on Oct 30, 2026 · price × 91.88M shares outstanding
- 52-week range
- $0.189 – $3.620 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $609,837 USDMedian day 1.24M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CNTX · Home | $0.189 USD | -0.013 (-6.2%) | 1,012,585 | $0.203 | $0.203 | $0.189 | $0.202 | Close on Oct 30, 2026 |
| Frankfurt:6K9 | €0.121 EUR | -0.071 (-37.0%) | — | €0.121 | €0.121 | €0.121 | €0.192 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CNTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.189 | -0.013 | -6.2% | $0.203 | $0.203 | $0.189 | 1,012,585 | |
| $0.202 | -0.010 | -4.5% | $0.211 | $0.215 | $0.200 | 1,308,370 | |
| $0.211 | -0.023 | -10.0% | $0.232 | $0.238 | $0.211 | 1,526,506 | |
| $0.235 | -0.005 | -2.2% | $0.232 | $0.242 | $0.220 | 1,810,190 | |
| $0.240 | +0.001 | +0.4% | $0.239 | $0.247 | $0.229 | 580,331 | |
| $0.239 | +0.003 | +1.3% | $0.228 | $0.240 | $0.215 | 1,484,900 | |
| $0.236 | +0.005 | +2.2% | $0.234 | $0.236 | $0.217 | 1,587,100 | |
| $0.231 | -0.013 | -5.3% | $0.248 | $0.248 | $0.223 | 1,165,300 | |
| $0.244 | +0.006 | +2.5% | $0.238 | $0.253 | $0.228 | 724,400 | |
| $0.238 | -0.006 | -2.5% | $0.243 | $0.267 | $0.230 | 843,400 | |
| $0.244 | +0.003 | +1.2% | $0.258 | $0.270 | $0.222 | 2,235,700 | |
| $0.241 | -0.015 | -5.9% | $0.252 | $0.273 | $0.236 | 1,337,400 | |
| $0.256 | -0.019 | -6.9% | $0.272 | $0.272 | $0.250 | 960,600 | |
| $0.275 | -0.030 | -9.8% | $0.301 | $0.306 | $0.270 | 1,253,900 | |
| $0.305 | +0.001 | +0.3% | $0.294 | $0.308 | $0.290 | 503,300 | |
| $0.304 | +0.005 | +1.7% | $0.300 | $0.310 | $0.298 | 588,700 | |
| $0.299 | -0.014 | -4.5% | $0.311 | $0.317 | $0.295 | 916,600 | |
| $0.313 | -0.009 | -2.8% | $0.316 | $0.323 | $0.311 | 464,200 | |
| $0.322 | -0.015 | -4.5% | $0.339 | $0.362 | $0.318 | 898,700 | |
| $0.337 | +0.027 | +8.7% | $0.310 | $0.340 | $0.310 | 1,001,300 | |
| $0.310 | -0.004 | -1.3% | $0.312 | $0.317 | $0.303 | 329,200 | |
| $0.314 | +0.014 | +4.7% | $0.309 | $0.320 | $0.299 | 1,138,300 | |
| $0.300 | -0.019 | -6.0% | $0.331 | $0.331 | $0.297 | 1,192,700 | |
| $0.319 | -0.007 | -2.1% | $0.323 | $0.332 | $0.312 | 849,400 | |
| $0.326 | -0.020 | -5.8% | $0.349 | $0.349 | $0.321 | 1,551,800 | |
| $0.346 | -0.025 | -6.7% | $0.371 | $0.380 | $0.345 | 1,324,500 | |
| $0.371 | -0.012 | -3.1% | $0.380 | $0.389 | $0.363 | 880,200 | |
| $0.383 | -0.006 | -1.5% | $0.390 | $0.395 | $0.370 | 1,107,100 | |
| $0.389 | +0.014 | +3.7% | $0.389 | $0.397 | $0.370 | 539,000 | |
| $0.375 | +0.007 | +1.9% | $0.379 | $0.388 | $0.364 | 770,200 | |
| $0.368 | -0.015 | -3.9% | $0.389 | $0.400 | $0.368 | 1,209,200 | |
| $0.383 | +0.004 | +1.1% | $0.374 | $0.388 | $0.360 | 1,504,300 | |
| $0.379 | +0.015 | +4.1% | $0.370 | $0.390 | $0.360 | 2,128,000 | |
| $0.364 | +0.013 | +3.7% | $0.364 | $0.383 | $0.351 | 1,375,300 | |
| $0.351 | +0.001 | +0.3% | $0.350 | $0.384 | $0.350 | 2,004,900 | |
| $0.350 | -0.016 | -4.4% | $0.379 | $0.379 | $0.343 | 821,800 | |
| $0.366 | -0.004 | -1.1% | $0.373 | $0.373 | $0.360 | 740,600 | |
| $0.370 | -0.006 | -1.6% | $0.376 | $0.380 | $0.370 | 642,000 | |
| $0.376 | +0.014 | +3.9% | $0.360 | $0.378 | $0.350 | 1,097,500 | |
| $0.362 | -0.001 | -0.3% | $0.365 | $0.370 | $0.347 | 974,900 | |
| $0.363 | 0.000 | 0.0% | $0.371 | $0.375 | $0.355 | 1,441,300 | |
| $0.363 | -0.001 | -0.3% | $0.370 | $0.375 | $0.351 | 1,317,500 | |
| $0.364 | -0.026 | -6.7% | $0.389 | $0.390 | $0.360 | 1,814,700 | |
| $0.390 | +0.006 | +1.6% | $0.385 | $0.399 | $0.375 | 1,280,700 | |
| $0.384 | -0.032 | -7.7% | $0.410 | $0.423 | $0.381 | 3,038,000 | |
| $0.416 | -0.008 | -1.9% | $0.429 | $0.437 | $0.411 | 1,131,900 | |
| $0.424 | -0.011 | -2.5% | $0.429 | $0.439 | $0.417 | 1,029,300 | |
| $0.435 | -0.030 | -6.5% | $0.470 | $0.475 | $0.397 | 8,170,500 | |
| $0.465 | -0.035 | -7.0% | $0.492 | $0.504 | $0.460 | 1,818,100 | |
| $0.500 | -0.020 | -3.8% | $0.527 | $0.547 | $0.500 | 1,744,400 | |
| $0.520 | +0.032 | +6.6% | $0.486 | $0.523 | $0.483 | 1,987,500 | |
| $0.488 | -0.009 | -1.8% | $0.485 | $0.500 | $0.450 | 4,181,100 | |
| $0.497 | -0.033 | -6.2% | $0.530 | $0.530 | $0.490 | 3,336,400 | |
| $0.530 | +0.007 | +1.3% | $0.530 | $0.535 | $0.516 | 925,300 | |
| $0.523 | +0.017 | +3.4% | $0.498 | $0.535 | $0.490 | 1,263,800 | |
| $0.506 | +0.036 | +7.7% | $0.468 | $0.510 | $0.468 | 1,585,200 | |
| $0.470 | +0.004 | +0.9% | $0.478 | $0.480 | $0.452 | 1,360,100 | |
| $0.466 | +0.014 | +3.0% | $0.466 | $0.474 | $0.453 | 1,222,251 | |
| $0.452 | -0.032 | -6.5% | $0.490 | $0.490 | $0.432 | 2,323,732 | |
| $0.484 | -0.020 | -4.0% | $0.510 | $0.529 | $0.480 | 2,427,200 | |
| $0.504 | -0.189 | -27.3% | $0.505 | $0.540 | $0.490 | 4,337,300 | |
| $0.693 | +0.071 | +11.4% | $0.630 | $0.695 | $0.616 | 3,340,600 | |
| $0.622 | +0.018 | +3.0% | $0.603 | $0.639 | $0.600 | 945,400 | |
| $0.604 | +0.005 | +0.8% | $0.620 | $0.633 | $0.590 | 1,480,800 | |
| $0.599 | -0.008 | -1.3% | $0.600 | $0.615 | $0.579 | 964,900 | |
| $0.607 | -0.010 | -1.6% | $0.617 | $0.630 | $0.600 | 1,005,200 |
- Ticker
- NASDAQ:CNTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 9, 2026
Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 37 slides
Latest news
Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
Sep 9, 2026
Closed $0.37 (-1.6%) on Sep 9, 2026
Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
Aug 5, 2026
Closed $0.504 (-27.3%) on Aug 6, 2026
Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes
Jul 6, 2026
Closed $0.70 (+9.7%) on Jul 7, 2026
Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
Jun 15, 2026
Closed $0.679 (-51.2%) on Jun 15, 2026
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 27, 2026
Closed $2.98 (+13.3%) on May 27, 2026
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 18, 2026
Closed $2.15 (-0.5%) on May 18, 2026
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
May 6, 2026
Closed $2.33 (-3.3%) on May 7, 2026
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
Apr 2, 2026
Closed $2.72 (+2.6%) on Apr 2, 2026
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Mar 23, 2026
Closed $3.02 (+4.9%) on Mar 23, 2026
Context Therapeutics to Participate in Upcoming Investor Conferences
Feb 9, 2026
Closed $2.17 (-4.8%) on Feb 9, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 37 slides · August 2026
Technical Presentation (June 2026)
Technical · 31 slides · Jun 15, 2026
Investor Presentation (June 2026)
Investor deck · 44 slides · Jun 15, 2026
Investor Presentation (March 2026)
Investor deck · 35 slides · Mar 23, 2026
Context Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 72 in all · newest Sep 9, 2026 · oldest 2021
- Decks
- 25 decks · latest August 2026
Where Context Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CNTX · Home listing · This page | NASDAQ | United States | USD |
| gettex:6K9 | gettex | Germany | EUR |
| LS Exchange:A3CWBU | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3CWBU | Lang & Schwarz | Germany | EUR |
| BOATS:CNTX | BOATS | United States | USD |
| Frankfurt:6K9 | Frankfurt | Germany | EUR |
| Munich:6K9 | Munich | Germany | EUR |
| Stuttgart:6K9 | Stuttgart | Germany | EUR |
| Tradegate:6K9 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Context Therapeutics Inc.